Actively Recruiting
Study of Factors Affecting Recurrence After Thermal Ablation in Patients with Papillary Thyroid Carcinoma
Led by Beijing Friendship Hospital · Updated on 2024-01-30
600
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying patients with papillary thyroid carcinoma PTC who have undergone thermal ablation at a hospital since February 2023. The study aims to analyze factors that may influence the recurrence of PTC after this treatment. Data collected include demographic information, ultrasound results, laboratory tests, and thyroid disease-related scales measuring fatigue, depression, and stress. The study involves no additional interventions beyond the thermal ablation already received by participants. Ultrasound and pathology are used to confirm diagnosis and characteristics of the thyroid nodules before treatment. Follow-up occurs for one to five years to observe the recurrence of PTC. Participants provide demographic and medical data before and after ablation. Researchers monitor recurrence using ultrasound and assess thyroid-related symptoms through questionnaires. The primary outcome measured is the rate of PTC recurrence over one to five years. The study is observational, with no experimental treatment assigned, and participants are monitored over time to better understand recurrence risks.
CONDITIONS
Brief Title
A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma
Research Team
X
Xianquan Shi, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
